(Q43631503)

25 November 2017

title

Tolerability of antihypertensive drugs in a community-based setting (English)

1 reference

25 November 2017

Grégoire JP

1

1 reference

25 November 2017

Moisan J

2

1 reference

25 November 2017

Guibert R

3

1 reference

25 November 2017

Ciampi A

4

1 reference

25 November 2017

Milot A

5

1 reference

25 November 2017

Côté I

6

1 reference

25 November 2017

Gaudet M

7

1 reference

25 November 2017

publication date

1 May 2001

1 reference

25 November 2017

published in

Clinical Therapeutics

1 reference

25 November 2017

volume

23

1 reference

25 November 2017

issue

5

1 reference

25 November 2017

page(s)

715-726

1 reference

Blood pressure, stroke, and coronary heart disease. Part 1, Prolonged differences in blood pressure: prospective observational studies corrected for the regression dilution bias

25 November 2017

cites work

1 reference

https://api.crossref.org/works/10.1016%2FS0149-2918%2801%2980021-7

7 January 2021

Prevalence of Hypertension in the US Adult Population : Results From the Third National Health and Nutrition Examination Survey, 1988-1991

1 reference

https://api.crossref.org/works/10.1016%2FS0149-2918%2801%2980021-7

7 January 2021

Trends in the Prevalence, Awareness, Treatment, and Control of Hypertension in the Adult US Population : Data From the Health Examination Surveys, 1960 to 1991

1 reference

https://api.crossref.org/works/10.1016%2FS0149-2918%2801%2980021-7

7 January 2021

Variations in compliance among hypertensive patients by drug class: implications for health care costs

1 reference

https://api.crossref.org/works/10.1016%2FS0149-2918%2801%2980021-7

7 January 2021

Safety and tolerability of losartan potassium, an angiotensin II receptor antagonist, compared with hydrochlorothiazide, atenolol, felodipine ER, and angiotensin-converting enzyme inhibitors for the treatment of systemic hypertension

1 reference

https://api.crossref.org/works/10.1016%2FS0149-2918%2801%2980021-7

7 January 2021

A randomized, placebo-controlled, double-blind, parallel study of various doses of losartan potassium compared with enalapril maleate in patients with essential hypertension

1 reference

https://api.crossref.org/works/10.1016%2FS0149-2918%2801%2980021-7

7 January 2021

Randomised trial of losartan versus captopril in patients over 65 with heart failure (Evaluation of Losartan in the Elderly Study, ELITE)

1 reference

https://api.crossref.org/works/10.1016%2FS0149-2918%2801%2980021-7

7 January 2021

Nitric oxide synthase gene polymorphisms, blood pressure and aortic stiffness in normotensive and hypertensive subjects

1 reference

https://api.crossref.org/works/10.1016%2FS0149-2918%2801%2980021-7

7 January 2021

Discontinuation of and changes in treatment after start of new courses of antihypertensive drugs: a study of a United Kingdom population

1 reference

https://api.crossref.org/works/10.1016%2FS0149-2918%2801%2980021-7

7 January 2021

Continuation of initial antihypertensive medication after 1 year of therapy.

1 reference

https://api.crossref.org/works/10.1016%2FS0149-2918%2801%2980021-7

7 January 2021

Angiotensin receptor antagonists: focus on losartan

1 reference

https://api.crossref.org/works/10.1016%2FS0149-2918%2801%2980021-7

7 January 2021

Patient-perceived side effects to antihypertensive drugs.

1 reference

https://api.crossref.org/works/10.1016%2FS0149-2918%2801%2980021-7

7 January 2021

Prevalence of cough during angiotensin-converting enzyme inhibitor therapy

1 reference

https://api.crossref.org/works/10.1016%2FS0149-2918%2801%2980021-7

7 January 2021

Prospective trial on captopril-related cough

1 reference

https://api.crossref.org/works/10.1016%2FS0149-2918%2801%2980021-7

7 January 2021

Treatment of ACE inhibitor-induced cough

1 reference

https://api.crossref.org/works/10.1016%2FS0149-2918%2801%2980021-7

7 January 2021

10.1016/S0149-2918(01)80021-7

Identifiers

DOI

1 reference

25 November 2017

1 reference